-transparent.png){kind=logo}
An exceptionally high serum erythropoietin (EPO) activity was documented in an anephric patient with severe anemia who required transfusions every 4 weeks. The patient's serum EPO was comparable to normal human urinary EPO in the polycythemic mouse assay and was neutralized by an antiserum against EPO. The patient's serum inhibited EPO stimulated-heme synthesis by normal human marrow cells in vitro. This finding suggests that an inhibitor played an important role in causing the anemia of this uremic patient.
Related Publications
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
January 1993,
Nephron,
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
August 1992,
The American journal of medicine,
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
January 1978,
Nephron,
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
October 1969,
Annals of surgery,
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
April 1979,
Kidney international,
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
January 1971,
Journal of surgical oncology,
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
October 2005,
Mayo Clinic health letter (English ed.),
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
October 1997,
Obstetrics and gynecology,
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
February 1968,
Blood,
J A Ortega, and
M H Malekzadeh, and
P P Dukes, and
A Ma, and
A V Pennisi, and
R N Fine, and
N A Shore
January 1969,
The Journal of laboratory and clinical medicine,
